Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole P Hachmann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|October 19, 2022
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6Nicole P Hachmann, Jessica Miller, Ai-Ris Y Collier, et al.
The New England Journal of Medicine|June 22, 2022
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5Nicole P Hachmann, Jessica Miller, Ai-Ris Y Collier, et al.
The New England Journal of Medicine|January 18, 2023
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1Jessica Miller, Nicole P Hachmann, Ai-Ris Y Collier, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsJingyou Yu, Ai-Ris Y Collier, Marjorie Rowe, et al.
The New England Journal of Medicine|March 16, 2022
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsJingyou Yu, Ai-Ris Y Collier, Marjorie Rowe, et al.
Science Translational Medicine|October 23, 2024
SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunityNinaad Lasrado, Marjorie Rowe, Katherine McMahan, et al.
Iscience|April 24, 2024
B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.SCatherine Jacob-Dolan, Michelle Lifton, Olivia C Powers, et al.
Vaccine|October 23, 2023
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86Ninaad Lasrado, Ai-Ris Y Collier, Nicole P Hachmann, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Waning Immunity Against XBB.1.5 Following Bivalent mRNA BoostersNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
The New England Journal of Medicine|January 11, 2023
Immunogenicity of BA.5 Bivalent mRNA Vaccine BoostersAi-Ris Y Collier, Jessica Miller, Nicole P Hachmann, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|October 19, 2022
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6Nicole P Hachmann, Jessica Miller, Ai-Ris Y Collier, et al.
The New England Journal of Medicine|June 22, 2022
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5Nicole P Hachmann, Jessica Miller, Ai-Ris Y Collier, et al.
The New England Journal of Medicine|January 18, 2023
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1Jessica Miller, Nicole P Hachmann, Ai-Ris Y Collier, et al.
Medrxiv : the Preprint Server for Health Sciences|February 16, 2022
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsJingyou Yu, Ai-Ris Y Collier, Marjorie Rowe, et al.
The New England Journal of Medicine|March 16, 2022
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 VariantsJingyou Yu, Ai-Ris Y Collier, Marjorie Rowe, et al.
Science Translational Medicine|October 23, 2024
SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunityNinaad Lasrado, Marjorie Rowe, Katherine McMahan, et al.
Iscience|April 24, 2024
B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.SCatherine Jacob-Dolan, Michelle Lifton, Olivia C Powers, et al.
Vaccine|October 23, 2023
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86Ninaad Lasrado, Ai-Ris Y Collier, Nicole P Hachmann, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Waning Immunity Against XBB.1.5 Following Bivalent mRNA BoostersNinaad Lasrado, Ai-Ris Y Collier, Jessica Miller, et al.
The New England Journal of Medicine|January 11, 2023
Immunogenicity of BA.5 Bivalent mRNA Vaccine BoostersAi-Ris Y Collier, Jessica Miller, Nicole P Hachmann, et al.
Pageof 2